Related by context. All words. (Click for frequent words.) 73 noninferiority 72 abacavir lamivudine 70 dalteparin 70 nicardipine 69 LPV r 69 caspofungin 69 ribavirin RBV 69 tirofiban 69 unfractionated heparin UFH 68 atorvastatin #mg 68 GP IIb IIIa inhibitors 68 unfractionated heparin 68 platelet inhibitor 68 ritonavir boosted 68 irbesartan 68 PEG IFN 67 #.#mg/dL 67 sirolimus eluting stents 67 micafungin 67 β blockers 67 mg qd 67 sirolimus eluting 67 comparator arm 67 zotarolimus eluting stent 67 Pemetrexed 67 mycophenolate mofetil 67 certolizumab 67 levosimendan 67 reteplase 67 eptifibatide 67 active comparator 67 pegylated interferon alpha 67 pegylated liposomal doxorubicin 66 eplerenone 66 liposomal amphotericin B 66 non inferiority 66 peginterferon alfa 2b 66 Combination therapy 66 Peg IFN 66 oral rivaroxaban 66 lispro 66 CCyR 66 sirolimus eluting stent 66 salmeterol fluticasone 66 alfa 2a 66 lopinavir r 66 tigecycline 66 abciximab 66 everolimus eluting stents 66 achieved statistical significance 66 LEXIVA r 66 IOP lowering 66 paclitaxel eluting stents 66 oxycodone CR 66 oral diclofenac 65 Taxus Stent 65 ertapenem 65 Vidaza azacitidine 65 FOLFOX6 65 idraparinux 65 tolterodine ER 65 mcg QD 65 NATRECOR ® 65 idarubicin 65 rt PA 65 mg tid 65 ACTEMRA TM 65 TPV r 65 ARB telmisartan 65 SVR# 65 boosted protease inhibitor 65 Patency 65 Doxil ® 65 titrated glipizide 65 tenecteplase 65 HBeAg negative patients 65 meropenem 65 infusional 65 interferon alfa 2b 65 plus GP IIb 65 paricalcitol 65 chlorthalidone 65 #mg BID [001] 65 complete cytogenetic response 65 Pegylated Liposomal Doxorubicin 65 β blocker 65 binary restenosis 65 doxorubicin docetaxel 65 BENICAR HCT 65 sorafenib Nexavar 65 tenofovir emtricitabine 65 invasive aspergillosis 65 relapsed MM 65 Cypher Stent 65 chlorambucil 65 galiximab 65 adriamycin 65 mitomycin 65 bendamustine 65 efavirenz EFV 65 subcutaneously administered 65 XIENCE V PROMUS Stent 65 protease inhibitor PI 65 rizatriptan 65 thienopyridines 65 ß blockers 65 administered subcutaneously 65 evaluating tivozanib 65 nondiabetic patients 65 5 Fluorouracil 65 FOLFOX4 65 morphometric vertebral fractures 64 candesartan cilexetil 64 darunavir ritonavir 64 nonrandomized 64 peginterferon alpha 2a 64 randomized multicenter trial 64 VELCADE melphalan 64 plus dexamethasone 64 prospectively defined 64 neostigmine 64 deferoxamine 64 amoxicillin clavulanate 64 virologic failure 64 mg TID 64 Helicobacter pylori eradication 64 thromboembolic events 64 piperacillin tazobactam 64 anti arrhythmic drug 64 ULORIC 64 fluvastatin 64 aldosterone antagonists 64 p ≤ 64 transdermal estradiol 64 voriconazole 64 clodronate 64 nilotinib 64 atazanavir ritonavir 64 Darusentan 64 mcg BID 64 carboplatin paclitaxel 64 p = NS 64 rFVIIa 64 Peginterferon Alfa 2a 64 saline placebo 64 interferon ribavirin 64 Dabigatran 64 lanthanum carbonate 64 alkylating agent 64 sitaxsentan 64 sirolimus stent 64 pegylated interferon alfa 64 nadolol 64 CR nPR 64 pimecrolimus cream 64 LMWH 64 eluting stent 64 doripenem 64 Nebulized 64 locoregional recurrence 64 CANCIDAS 64 cinacalcet 64 antiarrhythmic 64 q8h 64 RLAI 64 ribavirin USP 64 bivalirudin monotherapy 64 Known hypersensitivity 64 Xelox 64 ribavirin therapy 64 melphalan prednisone 64 azilsartan medoxomil 64 Bivalirudin 64 ceftazidime 64 TAXUS Express Stent 63 anagrelide 63 teriflunomide 63 Aptivus ® 63 FUSILEV enhances 63 piroxicam 63 colorectal liver metastases 63 biphasic insulin aspart 63 adjunctive placebo 63 tipranavir ritonavir 63 INVEGA ® 63 5-FU/LV 63 ablative therapy 63 % CI #.#-#.# [003] 63 fluticasone salmeterol 63 COMBIVIR 63 invasive candidiasis 63 metastatic GIST 63 DAPT 63 #mg QD [001] 63 Fondaparinux 63 ritonavir boosted lopinavir 63 AZT zidovudine Retrovir 63 pegylated interferons 63 pain palliation 63 clomipramine 63 #mg doses [002] 63 enalapril 63 EGFR TKI 63 HCl capsules 63 Femara letrozole 63 bolus injection 63 ABC/3TC 63 paroxysmal AF 63 mapatumumab 63 intravesical therapy 63 thalidomide Thalomid 63 macrolide antibiotic 63 Intravitreal 63 gadobutrol 63 clevidipine 63 glycoprotein IIb IIIa inhibitors 63 estramustine 63 mRCC 63 Losartan 63 ATACAND 63 olmesartan 63 pamidronate 63 alfuzosin 63 Folfox 63 tapentadol ER 63 sunitinib Sutent 63 sipuleucel T 63 aspirin heparin 63 adalimumab Humira 63 DES implantation 63 Perforomist Inhalation Solution 63 amphotericin B 63 pegylated interferon alpha 2a 63 iodixanol 63 alpha blocker 63 crizotinib PF # 63 plus ribavirin 63 PegIFN 63 concurrent chemoradiation 63 Randomized Evaluation 63 HBeAg seroconversion 63 response CCyR 63 aspirin clopidogrel 63 Dasatinib 63 PEGINTRON TM 63 mg QD 63 fallopian tube cancers 63 Epirubicin 63 statistically significant p = 63 FOLPI 63 fondaparinux sodium 63 benazepril 63 multicenter randomized placebo controlled 63 flutamide 63 Copegus ribavirin 63 ACTOS ® 63 fondaparinux 63 neoadjuvant 63 pharmacologically active isomer 63 dabigatran etexilate 63 labetalol 63 Non inferiority 63 genotypic resistance 63 angiotensin receptor blocker ARB 63 mesilate 63 IFN beta 63 achieved sustained virologic 63 carotid endarterectomy CEA 63 Abciximab 63 IIIa inhibitors 63 MAGE A3 ASCI 63 neurologic progression 63 plus prednisone 63 everolimus eluting stent 63 GnRH agonist 63 Kaletra lopinavir ritonavir 63 diclofenac sodium 63 cilostazol 63 Virologic 63 recurrent GBM 63 ziprasidone 63 cTnI 63 FOLFIRI 63 IM progesterone 63 bolus dose 63 recurrent glioblastoma multiforme 63 Enoxaparin 63 indinavir 63 % Confidence Interval 63 nab paclitaxel 63 antiarrhythmic drug 63 pegylated liposomal doxorubicin PLD 63 pegylated interferon alfa 2b 63 amisulpride 63 stable angina 63 rHuEPO 63 mycophenolic acid 63 VFEND 62 zoledronic acid Zometa 62 CIMZIA TM certolizumab pegol 62 Degarelix 62 GOUT 62 NMIBC 62 maximally tolerated dose 62 detectable HCV RNA 62 Dabigatran etexilate 62 metastatic malignant 62 postoperative chemotherapy 62 Ereska 62 aldosterone antagonist 62 nadroparin 62 glycoprotein IIb IIIa inhibitor 62 leukotriene receptor antagonists 62 Ziprasidone 62 glatiramer acetate 62 RE LY ® 62 adjuvant tamoxifen 62 subcutaneous enoxaparin 62 KRAS mutations occur 62 drug eluting stent implantation 62 timolol 62 divalproex sodium 62 isoproterenol 62 peginterferon alfa 2a 62 iloprost 62 oxaliplatin Eloxatin 62 CORDAPTIVE 62 phase IIIb 62 TAXUS Liberte Long 62 ketorolac 62 fibrinolytic therapy 62 analgesic efficacy 62 antiplatelet agent 62 Vascular Wrap 62 docetaxel Taxotere ® 62 bivalirudin 62 periprocedural 62 multicentre randomized 62 pan HDAC inhibitor 62 mg BID dose 62 assessing T DM1 62 viral kinetics 62 tipranavir 62 Stenting Trial CREST 62 DU #b 62 lipid lowering agents 62 mometasone furoate 62 Mg Uk 62 abacavir Ziagen 62 Tocilizumab 62 IIIa inhibitor 62 serum phosphorous 62 Aflibercept 62 sotalol 62 TO AVOID PREGNANCY WHILE 62 bevacizumab Avastin ® 62 CIMZIA TM 62 corrected QT interval 62 revascularizations 62 liposome injection 62 tacrolimus ointment 62 trials RCTs 62 pg mL 62 cetuximab Erbitux R 62 thrombus aspiration 62 otamixaban 62 difluprednate 62 oral levofloxacin 62 INTEGRILIN R 62 BUPHENYL R sodium phenylbutyrate 62 LNG IUS 62 antiretroviral naïve 62 nonoperative 62 PSA nadir 62 gemcitabine Gemzar 62 transthoracic 62 XIENCE V demonstrated 62 Meets Primary Endpoint 62 urate lowering therapy 62 droperidol 62 pCR 62 5 FU leucovorin 62 zolmitriptan 62 risperidone Risperdal 62 desvenlafaxine succinate 62 clopidogrel Plavix 62 Dacogen decitabine 62 PRADAXA #mg 62 achieved CCyR 62 thromboembolic complications 62 dose regimens 62 pegylated interferon peg IFN 62 reinfarction 62 Pegasys ® 62 beta blocker atenolol 62 serum phosphorus 62 liposomal doxorubicin 62 pharmacokinetic PK study 62 ug kg 62 ABVD 62 microbiological eradication 62 FEMALES SHOULD BE ADVISED 62 catheter occlusion 62 endoscopic remission 62 imipenem 62 ALVESCO 62 stent thromboses 62 stent binary restenosis 62 renal artery stenting 62 Telmisartan 62 non valvular atrial 62 Platinol 62 Ranolazine 62 NNRTI resistance 62 antimicrobial prophylaxis 62 BENICAR 62 cisplatin vinorelbine 62 imatinib resistant 62 liposomal formulation 62 potent CYP#A# inhibitors 62 imiquimod cream 62 enoxaparin 62 TAXUS Stent 62 elective PCI 62 NATRECOR R 62 BARACLUDE ® 62 rilpivirine 62 xanthine oxidase inhibitor 62 NSABP B 62 gemcitabine cisplatin 62 hemostatic efficacy 62 cefuroxime 62 EURIDIS 62 Capecitabine 62 terazosin 62 segment binary restenosis 62 mL/min/#.# m 2 62 Achieves Primary Endpoint 62 Moxifloxacin 62 achieved ACR# 62 Daptomycin 62 Pegylated interferon 62 fosbretabulin 62 posaconazole 62 goserelin 62 definite stent thrombosis 62 BoNTA 62 ritonavir boosted atazanavir 62 doxazosin 62 pharmacodynamics PD 62 Kaplan Meier analysis 62 undetectable HBV DNA 62 TAXUS p value 62 NEVO ™ 62 Capesaris 62 HCV SPRINT 62 Ambrisentan 62 coxib 62 fludarabine cyclophosphamide 62 capecitabine Xeloda 62 subcutaneous SC 62 insulin detemir 61 symptomatic carotid stenosis 61 lopinavir r arm 61 plasma kallikrein inhibitor 61 alpha 2a 61 daily subcutaneous injections 61 ARCOXIA 61 Flu Cy 61 remifentanil 61 subcutaneous insulin 61 selective modulator 61 postmenopausal osteoporotic women 61 ug dose 61 Posaconazole 61 Teriflunomide 61 decitabine 61 drotrecogin alfa activated 61 LV dysfunction 61 Peginterferon 61 Navelbine ® 61 Hazard Ratio 61 sustained virological response 61 mcg dose 61 Gilead Viread 61 atherosclerotic renal artery stenosis 61 QT QTc 61 serum urate 61 fulvestrant 61 Pegasys peginterferon alfa 2a 61 briakinumab 61 perioperatively 61 intravenously administered 61 tumor histology 61 SPRYCEL ® 61 #Gy 61 PERSEUS 61 aPTT 61 dosage regimens 61 antithrombotics 61 leuprorelin 61 Prospective Randomized Trial 61 atazanavir Reyataz 61 parecoxib 61 PREZISTA r 61 mm Stent 61 paclitaxel carboplatin 61 zonisamide SR 61 CYP#D# inhibitor 61 bovine thrombin 61 postprocedure 61 somatostatin analog 61 peginterferon alfa 61 neutropenic sepsis 61 tocilizumab 61 dexamethasone Decadron 61 dose atorvastatin 61 mCi kg 61 peg interferon 61 chemoradiation therapy 61 ezetimibe simvastatin 61 RE LY trial 61 mg clopidogrel 61 daily Infergen 61 K#N 61 hA# 61 interferon gamma 1b 61 randomized multicenter 61 Adefovir 61 hemodynamically significant 61 daunorubicin 61 QTc prolongation 61 #mg QD [002] 61 oral anticoagulation 61 nitroprusside 61 zoledronate 61 Engerix B 61 P = .# 61 intact parathyroid hormone 61 uridine triacetate 61 Sanofi Aventis Taxotere 61 epoetin alpha 61 low dose Iluvien 61 Telbivudine 61 atrophic vaginitis 61 ExTRACT TIMI 61 Melphalan 61 Adjunctive 61 CLL SLL 61 NAVISTAR R 61 immunomodulatory therapy 61 Mycophenolate Mofetil 61 #.#/#.# mmHg [001] 61 prospective multicenter 61 TDF FTC 61 HES CEL 61 velafermin 61 elevated troponin 61 Randomised 61 deep venous thromboses 61 pretest probability 61 naïve HCV 61 Pharmacokinetic studies 61 bezafibrate 61 fluorouracil leucovorin 61 pegylated interferon alfa 2a 61 -#.# log# 61 treatment naive genotype 61 intermittent dosing 61 administered intraperitoneally 61 KRN# 61 Hycamtin ® 61 peginterferon alfa 2a #KD 61 cyclophosphamide methotrexate 61 octreotide LAR 61 formoterol fumarate 61 antimuscarinic 61 doxorubicin cyclophosphamide 61 IV bolus 61 graft patency 61 Sandostatin R 61 ZOLINZA 61 4mg/kg 61 monophasic 61 surgical revascularization 61 workhorse lesions 61 CALGB # [002] 61 colposuspension 61 fosamprenavir 61 beta 1a 61 Myocardial Infarction Study 61 ACCOMPLISH 61 patients undergoing percutaneous 61 HCV RESPOND 2 61 angiotensin II receptor blocker 61 Hypotension 61 Vidaza ® 61 Operative mortality 61 urinary N telopeptide 61 zotarolimus 61 ACE inhibitor ramipril 61 intranasally administered 61 dacarbazine 61 intranasal formulation 61 intravenous dosing 61 antiplatelet drugs 61 placebo p = 61 milrinone 61 confidence interval #.#-#.# 61 VAPRISOL 61 Micardis ® 61 streptokinase 61 ACUITY trial 61 undetectable viral 61 dose dexamethasone 61 ximelagatran 61 Taxotere chemotherapy 61 mg kg dose 61 Aggrenox R 61 anthracycline taxane 61 rFSH 61 Fluticasone 61 pioglitazone Actos 61 pentoxifylline 61 relapsers 61 1mg 2mg 61 cefazolin 61 Randomized Phase 61 glulisine 61 lipid lowering drugs 61 TMC# r 61 factor Xa inhibitor 61 phase IIb clinical 61 NPH insulin 61 peginterferon 61 Darunavir 61 Ventavis ® 61 AGGRASTAT R Injection tirofiban 61 GP IIb IIIa inhibitor 61 receiving INTRON 61 FASLODEX 61 neointimal hyperplasia 61 tipranavir r 61 ibandronate 61 virologic response 61 intra arterial 61 attain statistical significance 61 headache nasopharyngitis 61 TLK# 61 tinzaparin 61 Carvedilol 61 palonosetron 61 nelfinavir 61 tenofovir Viread 61 platelet reactivity 61 darunavir r 61 latanoprost 61 Erlotinib 61 Sudhir Agrawal D.Phil 61 XELOX 61 non splenectomized 61 transarterial 61 trimethoprim sulfamethoxazole 61 CIMZIA ™ 61 Sirolimus eluting Coronary Stent 61 bisoprolol 61 Randomized controlled 61 antiandrogen 61 Endarterectomy 61 alteplase 61 lapatinib Tykerb 61 q#h 61 quetiapine risperidone 61 Irinotecan 61 μg kg 61 statin monotherapy 61 primary patency 61 Fluconazole 61 Pred Forte 61 oral allopurinol 61 Telithromycin 61 docetaxel Taxotere 61 metastatic renal cell carcinoma 61 captopril 61 ALA PDT 61 radiotherapy RT 61 cetuximab Erbitux 61 dexmedetomidine 61 glycated hemoglobin levels 61 Viread Emtriva 61 budesonide pMDI 61 mg m² 61 ALT elevation 61 AEGR 61 cisplatin gemcitabine 61 primary percutaneous coronary 61 Tipranavir 61 mg p = 61 Noxafil 61 tolvaptan 61 mg RDEA# 60 pharmacokinetic equivalence 60 8mg/kg 60 TMP SMX 60 infliximab monotherapy 60 CsA 60 XIENCE V stent 60 TMC# C# 60 pioglitazone HCl 60 dasatinib Sprycel 60 intima media thickness 60 strontium ranelate 60 mCi 60 hypofractionated 60 pegylated IFN 60 oral bisphosphonate 60 lenalidomide Revlimid R 60 HMG CoA reductase inhibitor 60 virus HCV protease inhibitor 60 Lenalidomide 60 microdose 60 mg hydrochlorothiazide 60 arterial thromboembolic events 60 oral ridaforolimus 60 #mg BID [003] 60 GW# [003] 60 MICARDIS 60 esophageal candidiasis 60 FDA defined valvulopathy 60 hemoglobin A1c levels 60 Ophena TM 60 pharmacokinetic interactions 60 Refractory Hodgkin Lymphoma 60 tranylcypromine 60 resectable pancreatic cancer 60 azathioprine 60 GPIIb IIIa inhibitors 60 hMG 60 dose clopidogrel 60 periprocedural MI 60 edifoligide 60 haematologic 60 vinorelbine tartrate 60 #mg dose [002] 60 mcg kg 60 rosiglitazone maleate 60 plus COPEGUS 60 HoLEP 60 statistical significance p 60 OPCAB 60 prostate carcinoma 60 Insulin detemir 60 TELCYTA 60 ZACTIMA 60 multicenter randomized controlled 60 phase IIb study 60 nefazodone 60 dasatinib Sprycel ® 60 oxymorphone ER 60 dual endothelin receptor antagonist 60 Crestor rosuvastatin 60 microbiologically evaluable 60 BEACOPP 60 SCIg 60 ARCALYST ® 60 3mg/kg 60 ISAR TEST 60 Nilotinib 60 interferon alfa 2a 60 Thrombolysis 60 angiographic outcomes 60 Diovan HCT 60 mTOR inhibitor 60 angiotensin converting enzyme inhibitors 60 rosuvastatin Crestor 60 transfemoral 60 lamotrigine 60 Myelodysplastic Syndrome MDS 60 ischemia driven 60 verteporfin 60 flecainide 60 interferon α 60 paclitaxel Taxol 60 bi ventricular pacing 60 lenalidomide dexamethasone 60 TAXOTERE R 60 log# IU mL 60 receiving VICTRELIS 60 Omacetaxine mepesuccinate 60 epirubicin cyclophosphamide 60 generation purine nucleoside 60 stage IIIb IV 60 polymyxin B 60 dimeglumine 60 mg ustekinumab 60 ACEIs 60 double blinded placebo 60 EDEMA3 60 CML CP 60 prasugrel Effient 60 placebo dexamethasone 60 PrandiMet TM 60 Pharmacokinetics PK 60 Adenoma Prevention 60 triamcinolone 60 PREZISTA ritonavir 60 DAS# remission 60 Carotid Revascularization Endarterectomy vs. 60 tamsulosin 60 infusional 5-FU/LV 60 adalimumab etanercept 60 TroVax ® 60 Fulvestrant 60 saphenous vein grafts 60 adenoma recurrence 60 HBeAg positive patients 60 Free Survival PFS 60 recurrent DVT 60 anti Xa 60 Gleevec resistant 60 randomized blinded 60 Apidra ® 60 diuretic chlorthalidone 60 Tolvaptan 60 Paxil paroxetine 60 cerebral vasospasm 60 MabCampath 60 arteriography 60 degarelix 60 beta estradiol 60 mg/m2 dose 60 nonfatal MI 60 Navelbine 60 paroxetine sertraline 60 Interferon beta 1b 60 Cypher Sirolimus 60 amprenavir 60 RE LY 60 ORENCIA ® 60 non squamous histology 60 Pivotal Phase III 60 CI -#.# 60 de novo kidney transplant 60 valdecoxib 60 olanzapine risperidone 60 #mg/#mg 60 complete cytogenetic 60 PEGylated Fab fragment 60 fluorouracil 60 lanreotide 60 platelet inhibition 60 biochemical relapse 60 carotid artery stenting 60 lumbar spine BMD 60 virologic suppression 60 simvastatin ezetimibe 60 MULTAQ 60 DMARD 60 pharmacokinetics PK 60 CorVue ™ 60 rebleeding 60 HOMA IR 60 NNT = 60 eluting stents 60 5 fluorouracil leucovorin 60 prospectively randomized 60 nonmetastatic prostate cancer 60 -#.# ± [002] 60 percutaneous intervention 60 tazobactam 60 Adalimumab 60 Cytoxan 60 Amrubicin 60 intravenous cyclophosphamide 60 symptomatic VTE 60 osteopenic 60 Monotherapy 60 TRANSFORMS 60 Abrupt discontinuation 60 ofloxacin 60 CYT# potent vascular disrupting 60 Pioglitazone 60 comparator PI r 60 imatinib Gleevec ® 60 mesalazine 60 intracoronary 60 orally inhaled 60 #mg dose [003] 60 INFERGEN 60 GORE VIABAHN Endoprosthesis 60 etanercept Enbrel 60 cediranib 60 canakinumab 60 tecarfarin 60 sulphonylureas 60 zalutumumab 60 highly emetogenic 60 dexpramipexole 60 clazosentan 60 plus 5-FU/LV 60 acitretin 60 PEGylated anti 60 experienced virologic failure 60 oblimersen 60 cyclophosphamide doxorubicin vincristine 60 pertuzumab 60 thalidomide dexamethasone 60 Fludara 60 gefitinib Iressa 60 underwent resection 60 timolol maleate 60 FOLFOX 60 thiazolidinedione TZD 60 fluoropyrimidine 60 Solid Tumors criteria 60 ibritumomab tiuxetan 60 Resolute stent 60 CYPHER Stent 60 adenosine injection 60 recurrent malignant glioma 60 colorectal adenoma 60 FLOMAX 60 QTc 60 carboplatin chemotherapy 60 Panzem NCD 60 dose cohort 60 trabectedin 60 #.#g/day 60 Adjuvant chemotherapy 60 Val HeFT 60 emtricitabine tenofovir 60 tenofovir DF 60 hours postdose 60 dosage regimen 60 MGd 60 direct thrombin inhibitors 60 leukemia CLL 60 Percutaneous Transluminal Coronary Angioplasty 60 MCyR 60 TORISEL 60 cytarabine daunorubicin 60 Bacillus Calmette Guerin BCG 60 pegfilgrastim 60 Tarceva TM 60 Orally administered 60 serum urate levels 60 prucalopride 60 budesonide formoterol 60 CYPHER R Sirolimus eluting 60 standard chemotherapy regimen 60 bortezomib Velcade 60 COZAAR 60 angiotensin converting enzyme inhibitor 60 Sirolimus Eluting 60 itraconazole Sporanox 60 superficial femoral 60 QD dosing 60 HBeAg 60 trandolapril 60 carotid intima media 60 tapentadol IR 59 antiangiogenic therapy 59 Linagliptin 59 DOXIL 59 Instanyl 59 Hormone Refractory Prostate Cancer 59 icatibant 59 progression TTP 59 allogeneic HSCT 59 bivalirudin alone 59 ticagrelor 59 fluticasone furoate 59 ALB # 59 Trandolapril 59 Prospective Randomized 59 lamivudine refractory patients 59 PEG interferon 59 DAS# CRP 59 primidone 59 Panzem R NCD 59 locoregional disease 59 posttreatment 59 acute HAE attacks 59 prospective multicenter randomized 59 biliary tract cancer 59 Dose Ranging Study 59 clinically evaluable 59 subanalysis 59 paclitaxel eluting 59 erlotinib Tarceva ® 59 -#.# log# copies mL 59 APTIVUS R 59 poor metabolizers 59 tobramycin 59 metastatic malignant melanoma 59 antithrombotic therapy 59 prespecified 59 μmol L 59 pomalidomide